Topics Coronavirus Vaccine | Coronavirus | Singapore
Excerpts from the interview:
- IHH’s expansion strategy in China
- China’s recovery remains strong, as is growth in IHH’s hospital in Hong Kong
- To open another hospital in Shanghai after starting facility in Chengdu; looking for opportunities at Greater Bay area in Hong Kong
- IHH’s operations in India, North Asia and Turkey are “not far” from becoming profitable
- IHH’s non-lira debt in its Turkish business to fall before year-end from 92 million euro as at November
- IHH sold its 50% interest in Apollo Gleneagles Hospital Ltd., a venture in India, and the transaction is expected to be completed by year-end.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor